Lilly and ParAllele to Launch Affy-based Drug-Metabolism Genotyping Assay in August or September | GenomeWeb

NEW YORK, March 17 (GenomeWeb News) - Eli Lilly and ParAllele plan to enable contract research organizations to use their joint genotyping assay in August or September, a Lilly official told Pharmacogenomics Reporter, GenomeWeb News' sister publication, this week.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.